Brief: Glaukos Announces Clinical Updates For Several Corneal Health Pipeline Programs
10/01/2023 21:16
Jan 10 (Reuters) - Glaukos Corp GKOS.N :
* GLAUKOS ANNOUNCES POSITIVE CLINICAL UPDATES FOR SEVERAL
CORNEAL
HEALTH PIPELINE PROGRAMS
* GLAUKOS CORP - COMMENCEMENT OF SUBJECT ENROLLMENT IN
EPIOXA™
PHASE 3 CONFIRMATORY TRIAL
* GLAUKOS CORP - PROMISING PHASE 2A RESULTS FOR GLK-301
(ILUTION -
DRY EYE DISEASE) SUPPORT PLANNED PHASE 2B STUDY TO COMMENCE IN
2023
Source text for Eikon: ID:nBw88G39La
Further company coverage: GKOS.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Glaukos
See all newsGlaukos says late-stage eye disease treatment shows lasting benefits after single dose
Brief: Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes In Keratoconus
US RESEARCH ROUNDUP-Boeing, Twilio, WP Carey
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Glaukos Corp reports results for the quarter ended June 30 - Earnings Summary